{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "RSN1",
        "Protein_Change": {
          "ref": "A",
          "alt": "A30P",
          "position": "30"
        },
        "variant_string_id": "RSN1 A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The accumulation of RS fibrils is a central component of PD pathogenesis, with the A30P mutation leading to altered lipid binding and oligomerization.",
          "judgment": "Yes",
          "reasoning": "The abstract and results section clearly state that RS fibril formation and accumulation are the primary mechanism of PD, and the A30P mutation is linked to this process."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of solution NMR to assess lipid binding, directly related to the known effects of the mutation on RS’s ability to bind lipids. This approach is established in the field for studying protein-lipid interactions and characterizing disease-associated variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A30P variant exhibits reduced lipid affinity and increased binding, directly supporting its pathogenic role through aberrant oligomerization and fibril formation, as demonstrated by the NMR data and consistent with previous studies."
    },
    {
      "variant_id": {
        "Gene": "RSN1",
        "Protein_Change": {
          "ref": "A",
          "alt": "E46K",
          "position": "46"
        },
        "variant_string_id": "RSN1 E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The accumulation of RS fibrils is a central component of PD pathogenesis, with the A30P mutation leading to altered lipid binding and oligomerization.",
          "judgment": "Yes",
          "reasoning": "The abstract and results section clearly state that RS fibril formation and accumulation are the primary mechanism of PD, and the A30P mutation is linked to this process."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of solution NMR to assess lipid binding, directly related to the known effects of the mutation on RS’s ability to bind lipids. This approach is established in the field for studying protein-lipid interactions and characterizing disease-associated variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The E46K variant exhibits an increased level of lipid binding, consistent with increased oligomerization and fibril formation, as demonstrated by the NMR data and consistent with previous studies."
    },
    {
      "variant_id": {
        "Gene": "RSN1",
        "Protein_Change": {
          "ref": "A",
          "alt": "A53T",
          "position": "53"
        },
        "variant_string_id": "RSN1 A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The accumulation of RS fibrils is a central component of PD pathogenesis, with the A30P mutation leading to altered lipid binding and oligomerization.",
          "judgment": "Yes",
          "reasoning": "The abstract and results section clearly state that RS fibril formation and accumulation are the primary mechanism of PD, and the A30P mutation is linked to this process."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of solution NMR to assess lipid binding, directly related to the known effects of the mutation on RS’s ability to bind lipids. This approach is established in the field for studying protein-lipid interactions and characterizing disease-associated variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A53T variant exhibits comparable lipid binding affinity to wild-type RS, supporting its involvement in the formation of RS fibrils and contributing to the pathogenesis of PD."
    }
  ]
}